Pharma Research

Hox Therapeutics and Vernalis Enter Collaboration to Advance Oncology Drug Discovery

Hox Therapeutics Ltd, a pioneering biotechnology company dedicated to developing targeted cancer therapies, and Vernalis (R&D) Ltd, a renowned subsidia...

 February 22, 2024 | News

Neurophth Completes Enrollment for Opvika® LHON Gene Therapy Trial in the U.S.

Neurophth Therapeutics, Inc. ("Neurophth"), a pioneer in gene therapies, today announced the successful completion of patient enrollment for its Phase I/II...

 February 20, 2024 | News

HKUST Neuroscientists Unveil Groundbreaking Blood Test for Alzheimer's with Over 96% Accuracy

Neuroscientists from the Hong Kong University of Science and Technology (HKUST), led by Prof. Nancy IP, have introduced a highly accurate universal diagnos...

 February 20, 2024 | News

NouvNeu001 Marks Milestone in iRegene's c Trial with Successful First Patient Dosing

It is reported that the multicenter, open-label clinical trial (Phase I/II) is meticulously crafted to systematically evaluate the safety, tolerability, an...

 February 06, 2024 | News

Fresenius Kabi Launches Posaconazole Injection for Fungal Infection Prevention/Treatment

Fresenius Kabi announced it has introduced Posaconazole Injection, a generic substitute for Noxafil®, for use in treating or preventing serious fungal ...

 January 30, 2024 | News

Glenmark, Jiangsu Alphamab, and 3D Medicines Ink Global License Deal for Envafolimab (KN035)

Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East ...

 January 26, 2024 | News

Caliway Receives Initial Approval for CBL-514 Phase 3 Fat Reduction Study

"We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the previous Pha...

 January 24, 2024 | News

Sagimet Biosciences Reports Positive Results in Phase 2b Trial of Denifanstat for F2/F3 NASH

-  Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD Activity Score) in ...

 January 24, 2024 | News

Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay

In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...

 January 22, 2024 | News

Complete Genomics and Gencove Partner for Bundled Low-Pass Whole Genome Sequencing Solution at PAG 31

The partnership will combine Gencove's platform for data analytics and management with Complete Genomics' sequencing products and automation capabilit...

 January 17, 2024 | News

SOPHiA GENETICS and Karkinos Healthcare Partner to Advance Cancer Research in India

SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge geno...

 January 15, 2024 | News

VerImmune and A*STAR Join Forces in Research Collaboration to Propel ViP Platform Development

The collaboration is centered around platform development and aims to develop a preclinical manufacturing platform, which will facilitate the generation of...

 January 11, 2024 | News

Shanghai Argo Partners with Novartis in Multi-Program RNAi Licensing and Collaboration

- Argo will receive upfront payments of $185 million from Novartis and is eligible to receive potential option and milestone payments as wel...

 January 08, 2024 | News

Kexing Biopharm Expands Global Portfolio with Eribulin Mesylate Injection

Eribulin Mesylate Injection is indicated for patients with locally advanced or metastatic breast cancer who have undergone at least two chemotherapy r...

 January 08, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close